Hepatocellular carcinoma

Javed Iqbal Farooqi; Rukhsana Javed Farooqi

Author(s)

Javed Iqbal Farooqi Department of Medicine and Gastroenterology, Saidu Medical College, Swat.

Rukhsana Javed Farooqi Department of Medicine and Gastroenterology, Saidu Medical College, Swat.

Abstract

Hepatocellular carcinoma (HCC) is a common cause of cancer mortality. Hepatitis B and C viruses, aflatoxin and alga toxin in the contaminated drinking water are the major etiological factors. Rapidly progressing medical imaging has resulted in the improved treatment results. Surgical resection has a major role for influencing prognosis of HCC. Local cancer therapies based on the advances in early diagnosis are progressing rapidly. Multimodality combination and sequential treatment has proved effective, unfortunately systemic chemotherapy for HCC remains disappointed. All of these have resulted in the improved prognosis df HCC.

Publication Details

Page(s) 776-782

DOI DOI not available

Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 12, Year: 2001

Request the full text from PASTIC

Keywords

Hepatectomy, Treatment outcome, Carcinoma, Hepatocellular

References

Lee RG . .livercelldysplasiaa)nd hepatocellulcaarrcinom ain BarlatSi. Expressionof urokinase-typeplasminogen cirrhosism:atchedcase-controsltudy, pathological activato(rU-PA), U-PA receptora,nd tissue-typePA analysisa, nd pathogenetihcypothesis. Hepatology messengerRNAs in human hepatocellulcarcinoma, 58 : 2234-9.

Wada Y .1998 .. Clinicopathological studyon hepatocellulcaarrcinomawith lymphocytic infiltratioHne.patology, 27 : 407-14.

Shimada M .1998 .Naturaklillercell activityin patientswith hepatocellulcaarrcinomaa: new prognosticindicatorafterhepatectomy. Cancer, 83 : 58-63.

Chen PJ,Yang PM .1997 .Clinicaland microbiological featureosfliverabscessaftetrransartercihaelmoembolizatiofnorhepatocelluclarcinomaA. mJGastroenterol, 92 : 2257-9.

Min M .1997 .TatsuzakHi, etal. Radiationtolerancoefcirrhotilciversin relation to the preservedfunctionalcapacity:analysisof patientswith hepatocellulcaarrcinomatreatedby focusedprotonbeamradiotheraplyo. tJRadial OncolBio! Phys, 38 : 367-72.

Liu CL .1998 .Rupturedhepatocellu larcarcinomaas a complicationoftransarteroialyl chemoembolizatioBn. rJSurg, 85 : 512-4.

.1997 .Acutehepaticfailurfeol lowingtranscatheaterrterieamlbolizatiofnorthetre at mentof hepatocellulcaarrcinomaD. igestion, 58 : 189-95.

. .Treatmentof unresectablehepatocellulcaarrcinomawith lipiodol chemoembolizationa: multicenterrandomizedtrial. JHepatol, 29 : 129-34.

Kim JS,Lin Y-M, JS .1997 .ChuangVP. A pilotstudyofthreescathetearrteriaclhemoembolizatioin thetreatment dimensionalconformarladiotherapiny unresectable of patientswith hepatocellulcaarrcinomaand main hepatocellulcaarrcinomaJ. Cancer, 79 : 2087-94.

Kaizu T .1998 .Hepatocellulcaarrcinomawithportal osseousmetastasefsromhepatocellulcaarrcinomaa: vein tumorthrombus:embolizationof arterioportal retrospectivsetudy of 57 patients.Am J Gastroenterol shunts. Radiology, 93 : 2163-71.

FanST. .1998 .The roleofhepaticarte rialembolizatioinn thetreatmeonftspontaneousrup 88. Hepatogastroenterology, 45 : 791-6.

--- .1997 .. ardiovasc InterventRadiol, 20 : 23-8.

. .. , 14 : 171-4.

.1998 .iPercutaneoutsre at mentof smallhepatictumorsby an expandableRF needleelectrodAem. JRoentgenol, 170 : 1015-22.

Bu W .1998 .EffectosfmatrixmetallopteinaseinhibitorBB-94 on livercancergrowthand metastasins a patient-likoerthotopicmodelLCI-D20. Hepatogastroenterology, 45 : 1056-61.

.1999 .. Preoperativpeortal vein embolizationa:n auditof 84 patientsH.epatology, : 1099-105.

Qin LX .1998 .WangXM. Alterationosfoncogene tumorsuppressogrenesand growthfactorins hep^ tocellulcaarrcinomaw: ith relatiotnotumorsize an> invasiveness. ChinMedJ, 111 : 313-8.

. .New human hepatocellulcaar cinoma(HCC) cellinewithhighlymetastatpicotentU(MHCC97) and itsexpressionofthefactorasssociate withmetastasisB. , 999 : 814-21.

.1998 .. the bestindicationforsurgery? J Hepatobiliary Pancreat Surg, 5 : 14-7.

.1998 .Earlyhepatocel lulacrarcinomasan entitywitha high rateofsurgi calcure. Hepatology, 28 : 1241-6.

Gad HA .1998 .LazarA. Analysisoffactorasffect ing outcomeaftehrepatectomoyfpatientswith liver cirrhosiasnd smallhepatocelluclarcinomaE. urJSurg, 164 : 513.

.1999 .. Shouldhepatomabe treatewdith hepaticresectionortransplanta-ti Cancer, 86 : 1151-8.

Izzo F .1998 .Outcomeof 67 patients withhepatocelluclarcinomdaetectedduringscreen ing of 1125 patientswith chronichepatitisA. nn Surg, 227 : 513-8.

Endo H .1999 .Kai-1 geneexpressionin TelomerasreeversetranscriptamseRNA expression hepatocellulcaarrcinomaand itsrelationshwipith intraand telomerasaectivityin hepatocellulcaarrcinoma. JGastroenterol, 34 : 83-7.

.1998 .KA11, a new metastasis suppressogrene, is relateind metastathicepatocellu larcarcinomaH. epatology, 28 : 1481-8.

.1998 .Ki-67 expressionas a prognosticmarkerin patientswith hepatocellular carcinomaJ. GastroenterolHepatol, 13 : 273-9.

Yeh KT .2000 .Mutationanalysis oftheBel10 gene in hepatocellulcaarrcinomaK. aohsiung. JMedSci, 16(7) : 332-8.

Ueno S,Aikou T . .AP-1 AreRequiredforconstitutive IL-8 GeneExpressionin hepatomacellsB. iochemBiophys ResCommun2999, 279(1) : 166-171.

.1998 .Expressionof human macrophagemetalloelastagesnee in hepatocellular carcinoma. Correlatiownith angiostatingeneration anditsclinicaslignificanceH.epatology, 28 : 986-93.

He NS .1999 .. SunJZ. Hepaticradioembolizatiwonith Yttrium-9g0lassmicrospherfeortreatmeonftprimary livercancerC.hinMedJ, 112 : 430-2.

.1997 .Prospectivreandomized trialof chemoembolizatiovnersusintra-arterial injectionof1311-labeled-lodizoeidlin thetreatmeonft hepatocelluclarcinomaH. epatology, 26 : 1156-61.

.1998 .PaseII and pharmacoki neticstudyofPaclitaxetlherapfyorunresectabhleepatocellulcaarrcinomapatientsB. rJCancer, 78 : 34-9.

.1998 .-fluorouraccilis, platiannd subcutaneousinterferonalpha-2bforpatientwsithlocallaydvancedhepatocel lulacrarcinomaO. ncology, 55 : 39-47.

. .-thymosin of singlesessionpercutaneouesthanolinjectionin and transcathetaerrteriaclhemoemobolizationin patientswith largehepatocellulcaarrcinomaC. ancer hepatocelluclarcinomapatientsa: preliminareyxpe1998;, 45 : 209-15.

Okada S .1997 .of hepatocellulcaarrcinomaafterpercutaneous CTL Therapyforpatientswith livercancerB. Cancer, 11 : 226-8.

. .. Prospectivreandomized controlletdrialcomparingpercutaneous aceticacidinjectionand percutaneouesthano linjectionforsmalhlepatocelluclarcinomaH.epatology, 27 : 67-72.

Yeh KH .1998 .FineRL. Biochemicalmodulationof doxordubicinby high-dosetamoxifenin thetreatment of advancedhepatocellulcaarrcinomaH. epatogastroenterology, 45 : 1955-60.

.1998 .Tamoxifen in treatmenotf hepatocellular carcinomaa: randomizedcontrollesdtudy. Gut, 42 : 442-7.

--- .1998 .tionoftransartercihaelmoembolizatioannd percut neous ethanolinjection a singlecenteranaly-s-. including132 patientst.ntJCancer, 79 : 601-5.

.2000 .. JCollPhysianSurgPakistan, 10(7) : 258-260.

.1998 .neous ethanolinjectionforthetreatmenotf larg hepatocellucaarrcinomal:ocatlherapeuteicffect long-termsurvivalrateE. Gut, 8 : 439-44.

Allgai eII .1998 .Tanaka K, NakamuraS, NumataK. The long-ter-i^ efficacoyfcombinedtranscatheaterrterieamlbolizj^- tionand percutaneouesthanolinjectionin. thetreJa mentofpatientwsithlargheepatocelluclaarrcinorri Cancer, 82 : 78-85.